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OBJECTIVES: To evaluate the content, clarity, and relevance of a new patient-
reported outcome questionnaire, the Alopecia Patient Assessment (APA), among 
women with breast cancer and alopecia. METHODS: 10 US subjects were 
recruited from oncology practices, breast cancer support websites, and other 
online sources, and asked to complete the APA, a five-item questionnaire 
assessing impact of hair loss on spending time with family/friends (Item #1), 
work (Item #2), ability to leave home (Item #3), self-image (Item #4), and feelings 
of embarrassment (Item #5). Subjects also completed a telephone interview 
about the APA. RESULTS: Mean age = 52 + 11 years (50% Caucasian, 60% 
married). All respondents felt the instructions were clear. Some suggestions 
included defining “hair loss” to include currently losing or already lost some or 
all of your hair, and to add instructions about how to respond if you typically 
wear a wig, hat or wrap. 90% found the questionnaire to be clear, with 70% 
reporting it was “very easy” to complete. One hundred percent correctly 
paraphrased the first 3 items, while 60% and 89% (8/9) correctly paraphrased 
Items 4 and 5, respectively. All respondents stated the 5 response options (“not 
at all” to “very much”) were clear. Although 78% (7/9) felt it was easy to recall 
“the past week,” 60% thought it would be clearer to use “the past 7 days.” Thirty 
percent were uncertain how to respond to Item #2, as they weren’t currently 
employed. Minor modifications included adding more general instructions for 
completion, using the past 7 days for the recall period, and adding a check box 
for Item #2 for those not employed. CONCLUSIONS: In general, the APA was 
clear, comprehensive, and relevant among breast cancer patients with alopecia. 
The APA can be considered for clinical trials to determine the patient perspective 
of this important symptom associated with chemotherapy.  
 
PRM144  
AN ADAPTABLE METHODOLOGY FOR THE DESIGN, IMPLEMENTATION AND 
CONDUCT OF A WEB-BASED SURVEY ASSESSING BURDEN OF ILLNESS AND 
RACIAL DIFFERENCES: CASE STUDY OF ADULT FEMALES WITH ACNE  
Yeomans K1, Kawata AK2, Bassel M1, Burk CT3, Daniels SR4, Wilcox TK5 
1United BioSource Corporation, Dorval, QC, Canada, 2United BioSource Corp., Bethesda, MD, 
USA, 3Health Outcomes Consultant, Laguna Beach, CA, USA, 4Allergan, Inc., Irvine, CA, USA, 
5United BioSource Corporation, Bethesda, MD, USA  
OBJECTIVES: To describe survey methodology used to evaluate the burden of illness 
and racial differences in adult female acne (AFA). METHODS: A targeted, web-based 
survey was used to recruit a racially diverse sample of US adult females (25-45 
years) with facial acne vulgaris from an existing pool of internet panelists. Subjects 
who self-reported ≥25 visible facial pimples at screening were eligible. Recruitment 
was stratified by age (50% 25-35; 50% 36-45 years) and race (50% White; 50% Non-
White [25% Black/African American; 25% Hispanic/Asian/Other]). Survey outcomes 
included: sociodemographic and clinical characteristics; resource utilization; 
treatment satisfaction; quality of life; perceptions; coping behaviors; work 
environment/productivity; anxiety/depression symptoms; and skin-specific 
treatment preferences (non-White females only). Validation rules were pre-
programmed into the survey to improve data quality. Descriptive statistics 
summarize results in the total sample; racial differences (White vs. non-White) 
were evaluated using descriptive statistics and t-test/chi-square analyses. 
RESULTS: The survey was fielded online from Oct-Nov 2011. A total of 7245 
panelists received survey invitations via email. Of 4112 survey respondents, 208 
(5.1%) were eligible and completed the survey. Mean age of sample was 35±6 years; 
48.6% non-White [Black (n=51); Hispanic (n=23); Asian (n=16); Other (n=11)]. Most 
females (80.3%) reported 25-49 visible pimples, followed by 50-75 (13.5%) and >75 
(6.3%). Median survey completion time was 24.5 minutes. CONCLUSIONS: Web-
based survey methodology with an existing pool of panelists permitted focused 
recruitment of respondents to reach targeted sample sizes in each age and 
race/ethnicity stratum. This method enabled recruitment of a targeted subset of 
patients, including non-White females and those with greater acne severity (≥50 
visible pimples). Web-based surveys are an effective method for collecting patient-
reported data for stratified patient cohorts, while minimizing both time and cost. 
This method was well suited for studying the burden of AFA in a real-world cohort.  
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OBJECTIVES: To quantify the usual severity range of commonly-used descriptors 
for pain, and to assess whether or not these different pain descriptors are 
associated with different ranges of the numeric rating (NRS) scale. METHODS: 
Subjects were recruited by web posting and subsequently screened. Those self-
reporting active pharmacological treatment for Migraine, Low Back Pain (LBP), 
Osteoarthritis (OA), or Rheumatoid Arthritis (RA) were scheduled for in-person 
interviews using card-sort exercises with pain descriptors selected by each 
subject. For each selected pain descriptor, subjects associated the descriptor with 
one number on an 11-point NRS scale to identify the degree of severity they 
usually experienced for that pain sensation. Each pain descriptor was 
summarized with descriptive statistics (mean, sd, range), to characterize the 
distribution of each word along the rating scale. RESULTS: Subjects (n=72) 
ranged between 19 and 84 years (mean age of 45). The majority (68%) was female, 
63% were working full- or part-time, and 61% were Caucasian. Of the 18 
descriptors used by the majority of subjects across conditions, the highest mean 
NRS values were found for EXCRUCIATING (mean=9.4), STABBING (7.6), and 
PIERCING (7.5). Low mean NRS values were found for TIGHT (5.0), STIFFNESS 
(5.0), and ANNOYING (5.1). Some descriptors were rated relatively consistently by 
subjects, as evidenced by low standard deviation and range (e.g., EXCRUCIATING, 
sd=1.1, range=5) while others showed more variability in placement on the scale 
(e.g., STIFFNESS, sd=2.8, range=10). CONCLUSIONS: While placement on an NRS 
ranges broadly, some descriptors are associated strongly with particular severity 
levels, while others are less precisely defined relative to severity. These patterns 
in pain scoring should be accounted for when selecting descriptors for a pain 
PRO measure.  
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OBJECTIVES: The Critical Path Institute’s (C-Path) ePRO Consortium, consisting 
of seven ePRO provider member firms, has developed a process for assessing the 
migratability of newly developed Clinical Outcome Assessment (COA) 
instruments. The objective of the electronic implementation assessment is to 
evaluate the viability of implementing a COA instrument on all currently 
available electronic platforms. METHODS: The electronic implementation 
assessment is conducted once a draft instrument has emerged from the item 
generation process as part of new instrument development. The assessment is 
conducted after a translatability assessment of the content has been completed. 
The assessment provides an item-level and instrument-level analysis of the 
instrument’s suitability for implementation on various electronic data collection 
platforms (i.e., tablet, handheld, interactive voice response (IVR), web, and digital 
pen). RESULTS: The instruments that have emerged from C-Path’s PRO 
Consortium’s Depression and Irritable Bowel Syndrome Working Groups have 
undergone the electronic implementation assessment process. Some assessment 
findings common to both instruments include: suggestions to modify the recall 
period or the way the recall period is expressed to subjects; identifying the 
translated character length of some items that may pose a concern for small-
screen devices; and highlighting that bold and underlined text are rendered 
differently on various operating systems and cannot be rendered on an IVR 
platform. Issues unique to each of the instruments were also detected. 
CONCLUSIONS: The PRO Consortium Working Groups have taken into account 
the feedback included in the electronic implementation assessments and have 
made changes to the draft COA instruments prior to additional instrument 
testing. The electronic implementation assessment has shown the ability to 
identify elements of COA instruments that should be modified to allow for easier 
implementation on a variety of electronic data collection platforms which is 
important for enhancing the quality of data collected with these instruments in 
future clinical trials.  
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OBJECTIVES: Patient reported health outcome data for children with cerebral 
palsy (CP) is limited by a lack of standardized protocols and effective data 
collection methods for this population. Children with CP present a spectrum of 
cognitive and communication abilities due to actual age, cognitive age, literacy, 
and motor/sensory impairment. Each factor impacts the ability to understand 
questions and provide responses about experiences and symptom status.  
For this study, we developed a novel approach for conducting concept elicitation 
interviews with CP patients (2-17 years) around spasticity-related pain. 
METHODS: Our interview protocol was developed using literature, interviews 
with CP specialists and input from parents/guardians. The methodology was 
flexible, allowing for individually tailored approaches based on the specific 
abilities of each patient. Techniques were adjusted based on: 1) screening data 
(age, estimated cognitive age, communication ability, Gross Motor Function 
Classification System [GMFCS] score); 2) information on strengths/limitations 
from parent/caregivers; and 3) observation during the interview. RESULTS: 
Interviews were conducted with 21 children and adolescents. Sixty seven 
percent of patients (N=14) had no cognitive deficits for their age, while 33% (N=7) 
had mild to moderate deficit. GMFCS levels ranged from I (38%; N=8) to V (29%; 
N=5). Components of successful interview techniques included: advance training 
of interviewers around common population idiosyncrasies; use of an “answer 
code” based on words, sounds, or gestures; use of partner assisted scanning; and 
use of a “multi-sensorial toolkit” of questions and aids. CONCLUSIONS: Children 
with CP represent a compromised population whose needs have been largely 
neglected in development of patient-reported outcomes (PROs). This 
multisensory methodology allowed us to collect usable data across a  
range of cognitive, physical, literacy, and age-ranges, and it offers a model for 
concept elicitation techniques in the growing field of child PROs, especially 
where clinical features of the participants’ condition make successful 
interviewing difficult.  
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